Rocket Doctor AI Inc. — Capital/Financing Update 2021

Jun 18, 2021

Form 51-102F3 Material Change Report

1. Name and Address of Company

Treatment.com International Inc.

#1500-1055 W Georgia S

Vancouver, BC, V6E 4N7 (the “Company”)

2.

Dates of Material Change(s)

June 17, 2021

3. News Release(s)

A news release was issued on June 18, 2021 and disseminated via Stockwatch and Baystreet News pursuant to section 7.1 of National Instrument 51–102.

4. Summaries of Material Changes

The Company announces that it has closed a non-brokered private placement offering for total gross proceeds of $5,004,000.

5. Full Description of Material Changes

News Release dated June 18, 2021– See Schedule “A”

6. Reliance on subsection 7.1(2) or (3) of National Instrument 51-102

Not applicable.

7. Omitted Information

No information has been omitted.

8. Executive Officer

Mr. John Fraser, CEO of the Company, is knowledgeable about the material change contained herein and may be reached at (612) 788-8900.

9. Date of Report

This report is dated June 18, 2021.

1

SCHEDULE “A” to the Material Change Report June 18, 2021

Treatment.com Closes $5,000,000 Private Placement

Vancouver, B.C. June 18, 2021 - Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE), a healthcare technology company that has developed an exclusive AI software to think like a doctor, is pleased to announce that it has closed a non-brokered private placement offering, as previously announced on May 12, 2021, for total gross proceeds of $5,004,000 (the “ Private Placement ”).

The Company has allotted and issued 1,000,800 common shares (the “ Shares ”) at a price of $5.00 per Share.

In relation to the Private Placement, the Company has paid finder’s fees of $185,140 and issued 36,880 finder’s warrants (the “ Finders Warrants ”) to arm’s-length parties. Each Finders Warrant is exercisable into one common share at a price of $5.00 per share, for a period of 18 months.

The Company will use the proceeds from the Private Placement towards the Company’s upcoming product launches, annual marketing plan and general working capital. All securities issued pursuant to the Private Placement will be subject to a hold period expiring October 18, 2021.

About Treatment.com

Treatment.com is a disruptive healthcare technology company that is harnessing the power of AI to help Canadians improve their health through personalized recommendations and insights. Based in Vancouver, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a complex AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment.com is the parent company of Cara. This summer, Cara will be empowering Canadians to take control of their health with the launch of an innovative mobile app powered by this exclusive AI engine.

For more investor information on Treatment.com please visit https://treatment.com/investors/.

On behalf of the Board of Directors,

“John Fraser”

John Fraser, Chief Executive Officer

2